Evaluation of the American Heart Association cardiovascular disease prevention guideline for women

Circulation: Cardiovascular Quality and Outcomes

Volumn 3, Issue 2, 2010, Pages 128-134

  Hsia, Judith ^a   Rodabough, Rebecca J ^b   Manson, Joann E ^c   Liu, Simin ^d   Freiberg, Matthew S ^e   Graettinger, William ^f   Rosal, Milagros C ^g   Cochrane, Barb ^h   Lloyd Jones, Donald ⁱ   Robinson, Jennifer G ^j   Howard, Barbara V ^k  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b USA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF NEVADA   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF IOWA   (United States)

^k MEDSTAR RESEARCH INSTITUTE   (United States)

more..

Author keywords

Prevention; Risk factors; Women

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASIAN; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; ETHNICITY; EXERCISE INTENSITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISPANIC; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NEGRO; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; UNITED STATES; WOMEN'S HEALTH;

AGED; ALGORITHMS; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; LOGISTIC MODELS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEX FACTORS; TIME FACTORS; UNITED STATES; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 77953364615     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.108.842385     Document Type: Article

References (28)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment panel III) final report. Circulation. 2002;106:3143-3421.
2. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.
3. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
4. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. CHD Risk Prediction Group: validation of the Framingham Coronary Heart Disease Prediction Scores: Results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187.
5. Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, Levy D. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20-24. (Pubitemid 38813447)
6. Ridker PM, Cook N. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. Circulation. 2005;111:657-658.
7. Sibley C, Blumenthal RS, Bairey Merz CN, Mosca L. Limitations of current cardiovascular disease risk assessment strategies in women. J Women's Health. 2006;15:54-56.
8. Tsang JLY, Mendelsohn A, Tan MKK, Hackam DG, Leiter LA, Fitchett D, Lin PJ, Grima E, Langer A, Goodman SG. Vascular Protection Registry and Guidelines Oriented Approach to Lipid Lowering Registry Investigators: discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. Am J Cardiol. 2008;102:1142-1145.
9. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG, Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW, Redberg RF, Scott R, Sherif K, Smith SC Jr, Sopko G, Steinhorn RH, Stone NJ, Taubert KA, Todd BA, Urbina E, Wenger NK. Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481-1501.
10. Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 1998;19:61-109.
11. Hays J, Hunt JR, Hubbell A, Anderson GL, Limacher M, Allen C, Rossouw JE. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003; 13: S18-S77.
12. Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B, Ockene J. The Women's Health Initiative Dietary Modification Trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13: S87-S97.
13. Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The Women's Health Initiative Postmenopausal Hormone Trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13: S78-S86.
14. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13: S107-S121.
15. Nilsson G, Hedberg P, Jonason T, Lönnberg I, Tenerz A, Forberg R, Ohrvik J. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Intern Med. 2008;19:520-526.
16. Howard BV, Criqui MH, Curb JD, Rodabough R, Safford MM, Santoro N, Wilson AC, Wylie-Rosett J. Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, Hispanic, and Asian/Pacific Islander women. Metabolism. 2003;52:362-371.
17. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716-725.
18. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs- Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178-187.
19. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM. Low-fat dietary pattern and risk of cardiovascular disease. JAMA. 2006;295:655-666.
20. Hsia J, Rodabough R, Rosal MC, Cochrane B, Howard BV, Snetselaar L, Frishman WH, Stefanick ML. Compliance with National Cholesterol Education Program Dietary and Lifestyle Guidelines among older women with self-reported hypercholesterolemia: the Women's Health Initiative. Am J Med. 2002;113:384-392.
21. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S. WHI Morbidity and Mortality Committee: outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003; 13: S122-S128.
22. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J. WHI Investigators: effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006;113:2425-2434.
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
24. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factors levels in the ATP-III risk assessment tool. Prev Med. 2008;47:619-623.
25. Christian AH, Mills T, Simpson SL, Mosca L. Quality of cardiovascular disease preventive care and physician/practice characteristics. J Gen Intern Med. 2006;21:231-237.
26. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans, 2005. 6th ed. Washington, DC: US Government Printing Office; January 2005.
27. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.
28. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res. 2008; 8: 60.